Clancy Paul J Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
14
Insider Sells Sum
$84.28M

Insider Activity of Clancy Paul J

According to the SEC Form 4 filings, Clancy Paul J, being in a position of

  1. director at Incyte Corporation,
    оver the last 12 months, has bought 0 shares, and sold 15000 shares for $1.42M,
    over all time since 2026-05-19, has bought 0 shares, and sold 15000 shares for $1.42M.

Biography of Clancy Paul J

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$1,423,9501100

Comparison of Insiders on Amount of Buys and Sells

2026-05-19SaleIncyte Corporation
INCY
director
15,000
0.0075%
$94.93$1.42M+22.28%
2017-04-25SaleBiogen Inc.
BIIB
Executive VP and CFO
19,784
0.0094%
$290.00$5.74M+1.1%
2017-03-13SaleBiogen Inc.
BIIB
Executive VP and CFO
19,782
0.0091%
$291.55$5.77M-0.64%
2013-09-18SaleBiogen Inc.
BIIB
Executive VP and CFO
53,570
0.0135%
$147.32$7.89M+23.26%
2013-09-16SaleBiogen Inc.
BIIB
Executive VP and CFO
181,682
0.0762%
$238.14$43.27M+26.13%
2013-04-30SaleBiogen Inc.
BIIB
Executive VP and CFO
28,978
0.0125%
$224.66$6.51M+11.84%
2013-04-29SaleBiogen Inc.
BIIB
Executive VP and CFO
18,246
0.0075%
$219.71$4.01M+9.34%
2012-02-01SaleBiogen Inc.
BIIB
Executive VP and CFO
42,800
0.0142%
$96.76$4.14M+18%
2012-01-03SaleBiogen Inc.
BIIB
Executive VP and CFO
40,488
0.0167%
$112.35$4.55M+22.89%
2011-04-28SaleBiogen Inc.
BIIB
Executive VP and CFO
19,016
0.0078%
$98.90$1.88M+10.23%
2008-09-19SaleBiogen Inc.
BIIB
Executive VP and CFO
1,553
0.0005%
$50.00$77,650-2.94%
2008-08-08SaleBiogen Inc.
BIIB
Executive VP and CFO
568
0.0002%
$50.66$28,777-2.91%
2008-07-01SaleBiogen Inc.
BIIB
Executive VP and CFO
4,208
0.0014%
$56.01$235,679-17%
2008-02-21SaleBiogen Inc.
BIIB
Executive VP and CFO
2,183
0.0007%
$60.39$131,838-12.97%
2008-02-12SaleBiogen Inc.
BIIB
Executive VP and CFO
958
0.0003%
$60.91$58,353-12.9%
Total: 15
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.